DK0741574T3 - Oral dosisform indeholdende colestipol som bærer for sure, aktive stoffer samt fremgangsmåde til dens fremstilling - Google Patents
Oral dosisform indeholdende colestipol som bærer for sure, aktive stoffer samt fremgangsmåde til dens fremstillingInfo
- Publication number
- DK0741574T3 DK0741574T3 DK95904434T DK95904434T DK0741574T3 DK 0741574 T3 DK0741574 T3 DK 0741574T3 DK 95904434 T DK95904434 T DK 95904434T DK 95904434 T DK95904434 T DK 95904434T DK 0741574 T3 DK0741574 T3 DK 0741574T3
- Authority
- DK
- Denmark
- Prior art keywords
- carrier
- pct
- active substances
- colestipol
- acidic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4402379A DE4402379C2 (de) | 1994-01-27 | 1994-01-27 | Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung |
PCT/EP1994/004082 WO1995020394A1 (de) | 1994-01-27 | 1994-12-08 | Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0741574T3 true DK0741574T3 (da) | 2002-09-23 |
Family
ID=6508812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95904434T DK0741574T3 (da) | 1994-01-27 | 1994-12-08 | Oral dosisform indeholdende colestipol som bærer for sure, aktive stoffer samt fremgangsmåde til dens fremstilling |
Country Status (22)
Country | Link |
---|---|
US (1) | US5858344A (da) |
EP (1) | EP0741574B1 (da) |
JP (1) | JP3701971B2 (da) |
KR (1) | KR100439311B1 (da) |
AT (1) | ATE218371T1 (da) |
AU (1) | AU697353B2 (da) |
CA (1) | CA2182417C (da) |
CZ (1) | CZ291006B6 (da) |
DE (2) | DE4402379C2 (da) |
DK (1) | DK0741574T3 (da) |
ES (1) | ES2177622T3 (da) |
FI (1) | FI116880B (da) |
HU (1) | HU223317B1 (da) |
IL (1) | IL112435A (da) |
MY (1) | MY113340A (da) |
NO (1) | NO963143L (da) |
NZ (1) | NZ277777A (da) |
PL (1) | PL315619A1 (da) |
PT (1) | PT741574E (da) |
SK (1) | SK97296A3 (da) |
WO (1) | WO1995020394A1 (da) |
ZA (1) | ZA95638B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403367B1 (en) * | 1994-07-07 | 2002-06-11 | Nanogen, Inc. | Integrated portable biological detection system |
DE19615820A1 (de) * | 1996-04-06 | 1997-10-09 | Holger Specht | Zahnpflegemittel und Verfahren zu seiner Herstellung |
US20030180249A1 (en) * | 2002-03-18 | 2003-09-25 | Khanna Satish Chandra | Dosage forms for hygroscopic active ingredients |
CA2938564C (en) | 2006-11-07 | 2017-04-11 | The Procter & Gamble Company | Fiber containing compositions and methods of making and using same |
US7767248B2 (en) * | 2007-02-02 | 2010-08-03 | Overly Iii Harry J | Soft chew confectionary with high fiber and sugar content and method for making same |
AU2022289297A1 (en) | 2021-06-07 | 2023-12-07 | University Of Tsukuba | Polymerized valproic acid and use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ191762A (en) * | 1978-10-19 | 1982-09-14 | Merck & Co Inc | Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin |
US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
DE3366838D1 (en) * | 1982-03-01 | 1986-11-20 | Efamol Ltd | Pharmaceutical composition |
US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
EP0409432A3 (en) * | 1989-07-20 | 1991-12-11 | Warner-Lambert Company | Confectionery delivery system |
CA2040865C (en) * | 1990-05-15 | 2002-07-23 | James L. Bergey | Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor |
-
1994
- 1994-01-27 DE DE4402379A patent/DE4402379C2/de not_active Expired - Fee Related
- 1994-12-08 US US08/693,101 patent/US5858344A/en not_active Expired - Lifetime
- 1994-12-08 WO PCT/EP1994/004082 patent/WO1995020394A1/de active IP Right Grant
- 1994-12-08 DE DE59410133T patent/DE59410133D1/de not_active Expired - Lifetime
- 1994-12-08 PT PT95904434T patent/PT741574E/pt unknown
- 1994-12-08 NZ NZ277777A patent/NZ277777A/en not_active IP Right Cessation
- 1994-12-08 PL PL94315619A patent/PL315619A1/xx unknown
- 1994-12-08 SK SK972-96A patent/SK97296A3/sk unknown
- 1994-12-08 HU HU9602041A patent/HU223317B1/hu not_active IP Right Cessation
- 1994-12-08 DK DK95904434T patent/DK0741574T3/da active
- 1994-12-08 CA CA002182417A patent/CA2182417C/en not_active Expired - Fee Related
- 1994-12-08 AU AU13127/95A patent/AU697353B2/en not_active Ceased
- 1994-12-08 EP EP95904434A patent/EP0741574B1/de not_active Expired - Lifetime
- 1994-12-08 AT AT95904434T patent/ATE218371T1/de active
- 1994-12-08 ES ES95904434T patent/ES2177622T3/es not_active Expired - Lifetime
- 1994-12-08 KR KR1019960704025A patent/KR100439311B1/ko not_active IP Right Cessation
- 1994-12-08 CZ CZ19962213A patent/CZ291006B6/cs not_active IP Right Cessation
- 1994-12-08 JP JP51984995A patent/JP3701971B2/ja not_active Expired - Fee Related
-
1995
- 1995-01-24 IL IL11243595A patent/IL112435A/en not_active IP Right Cessation
- 1995-01-26 ZA ZA95638A patent/ZA95638B/xx unknown
- 1995-01-26 MY MYPI95000183A patent/MY113340A/en unknown
-
1996
- 1996-07-26 NO NO963143A patent/NO963143L/no unknown
- 1996-07-26 FI FI962985A patent/FI116880B/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HU223317B1 (hu) | 2004-05-28 |
EP0741574A1 (de) | 1996-11-13 |
PT741574E (pt) | 2002-11-29 |
HU9602041D0 (en) | 1996-09-30 |
WO1995020394A1 (de) | 1995-08-03 |
DE59410133D1 (de) | 2002-07-11 |
FI962985A (fi) | 1996-07-26 |
AU697353B2 (en) | 1998-10-01 |
CZ221396A3 (en) | 1997-01-15 |
CA2182417C (en) | 2007-04-17 |
CZ291006B6 (cs) | 2002-11-13 |
HUT74434A (en) | 1996-12-30 |
AU1312795A (en) | 1995-08-15 |
IL112435A0 (en) | 1995-03-30 |
US5858344A (en) | 1999-01-12 |
SK97296A3 (en) | 1997-04-09 |
IL112435A (en) | 1999-01-26 |
CA2182417A1 (en) | 1995-08-03 |
JPH09511488A (ja) | 1997-11-18 |
NZ277777A (en) | 1997-01-29 |
KR100439311B1 (ko) | 2005-08-17 |
ES2177622T3 (es) | 2002-12-16 |
ZA95638B (en) | 1995-10-25 |
PL315619A1 (en) | 1996-11-25 |
NO963143L (no) | 1996-09-24 |
JP3701971B2 (ja) | 2005-10-05 |
ATE218371T1 (de) | 2002-06-15 |
KR970700505A (ko) | 1997-02-12 |
MY113340A (en) | 2002-01-31 |
DE4402379C2 (de) | 1997-09-25 |
FI962985A0 (fi) | 1996-07-26 |
DE4402379A1 (de) | 1995-08-03 |
EP0741574B1 (de) | 2002-06-05 |
FI116880B (fi) | 2006-03-31 |
NO963143D0 (no) | 1996-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR003415A1 (es) | Compuestos analogos de lactacistina, metodo para inhibir la proteolisis dependiente de proteasoma, metodo para identificar un proceso biologico mediado por proteolisis dependiente de proteasoma, uso de dichos compuestos para preparar un medicamento para tratar una condicion mediada por proteolisis dependiente de proteasoma. | |
DK0739197T3 (da) | Konserverede oftalmiske lægemiddelpræparater, som indeholder polymere kvaternære ammoniumforbindelser | |
MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
HU9600572D0 (en) | Medicament for inhibiting gastric acid secretion, multiple unit tablated dosage form | |
ATE146360T1 (de) | Gonadotropin enthaltende gefriergetrocknete troepfen | |
BG101781A (en) | Active substance-containing solid preparation | |
EP1078628A3 (en) | Multiple unit tableted dosage form | |
ITMO920035A1 (it) | Flacone contagocce particolarmente per prodotti farmaceutici attivabili all'uso per miscelazione | |
DE69034226D1 (de) | Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu | |
BR0211198A (pt) | Composições farmacêuticas e seu uso | |
DK0741574T3 (da) | Oral dosisform indeholdende colestipol som bærer for sure, aktive stoffer samt fremgangsmåde til dens fremstilling | |
ATE245974T1 (de) | Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung | |
DE69624563D1 (de) | Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff | |
DE59510583D1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
CA2185883A1 (en) | The use of dimeticone as a transport and carrier system and/or drug delivery system | |
FR2652590B1 (fr) | Exopolymere extracellulaire, son procede de preparation et compositions pharmaceutiques le contenant. | |
NO980175L (no) | Anvendelse av kationiske biopolymerer for å fremstille antiflassmidler | |
PE20011042A1 (es) | Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan | |
NO964905D0 (no) | Substituerte benzendikarboksylsyre-diguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
AU5662996A (en) | Compounds and compositions for delivering active agents | |
IT1251993B (it) | Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico | |
JO1881B1 (en) | Formula II for multi unit disc calibration | |
EP0131698A3 (en) | Guanabenz pharmaceutical composition | |
JO1880B1 (en) | Format 1 for multi-unit calibration discs |